Organization Overview
aldesleukin (Proleukin) (2 trials)
allogeneic hematopoietic stem cells (Hemacord) (2 trials)
allogeneic natural killer cells (3 trials)
allogeneic stem cells (1 trial)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (1 trial)
cyclophosphamide (cytoxan) (6 trials)
cytarabine (cytosar-u) (2 trials)
etoposide (vepesid) (2 trials)
fludarabine (fludara) (3 trials)
melphalan (alkeran) (2 trials)
Hematologic Neoplasms (Phase 2)
Histiocytosis (Phase 2)
Immunologic Deficiency Syndromes (Phase 2)
Leukemia (Phase 2)
Leukemia, Lymphoid (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myelomonocytic, Juvenile (Phase 2)
Lymphoma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Neoplasms (Phase 2)
Sarcoma, Myeloid (Phase 2)
Severe Combined Immunodeficiency (Phase 2)